Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Fortschritte Der Neurologie-Psychiatrie|June 1, 1996
[Significance of primary negative symptoms in schizophrenic and other psychiatric patients]H Gerbaldo, F Müller-SiechenederMMW Fortschritte Der Medizin|March 23, 2000
[Depression and suicidal behavior more effectively controlled by a team approach. Pilot project to optimize diagnosis and therapy]U Hegerl, O Seemann, F Müller-SiechenederEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 1, 1995
Dopamine agonists in schizophrenia: a reviewO Benkert, F Müller-Siecheneder, H WetzelJournal of Clinical Psychopharmacology|April 29, 1998
Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndromeF Müller-Siecheneder, M J Müller, A Hillert, et al.Schizophrenia Research|August 28, 1998
Evaluation of standardized rater training for the Positive and Negative Syndrome Scale (PANSS)M J Müller, W Rossbach, P Dannigkeit, et al.Psychiatry Research|March 9, 2000
Antipsychotic effects and tolerability of the sigma ligand EMD 57445 (panamesine) and its metabolites in acute schizophrenia: an open clinical trialM J Müller, G Gründer, H Wetzel, et al.Neuropsychobiology|November 28, 2000
Association study of suicidal behavior and affective disorders with a genetic polymorphism in ABCG1, a positional candidate on chromosome 21q22.3D Rujescu, I Giegling, N Dahmen, et al.Pharmacopsychiatry|October 7, 2004
Subchronic effects of olanzapine on sleep EEG in schizophrenic patients with predominantly negative symptomsM J Müller, W Rossbach, K Mann, et al.Psychological Medicine|January 8, 2008
Vagus nerve stimulation for depression: efficacy and safety in a European studyT E Schlaepfer, C Frick, A Zobel, et al.Pageof 1